Eli Ipp
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Nephrology top 2%
Papers in
-
- Diabetes Management and Research 18
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 7
- Surgery 31
- Pancreatic function and diabetes 29
- Co-authors
- Roger H. Unger (13 shared papers)Richard Dobbs (9 shared papers)Hsu-Fang Chou (8 shared papers)V. Harris (4 shared papers)Lelio Orci (5 shared papers)Pauline Genter (13 shared papers)Nancy Berman (9 shared papers)Wylie Vale (5 shared papers)
- Journals
- Diabetes (11 papers)The Journal of Clinical Endocrinology & Metabolism (8 papers)Life Sciences (4 papers)American Journal of Physiology-Endocrinology and Metabolism (4 papers)Diabetes Care (4 papers)
- Partner nations
- United StatesTaiwanSwitzerland
In The Last Decade
Eli Ipp
85 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 115
- Endocrinology, Diabetes and Metabolism 948
- Nephrology 272
- Endocrine and Autonomic Systems 180
- Surgery 1.0k
- Cellular and Molecular Neuroscience 461
Countries citing papers authored by Eli Ipp
This map shows the geographic impact of Eli Ipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Ipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Ipp more than expected).
Fields of papers citing papers by Eli Ipp
This network shows the impact of papers produced by Eli Ipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Ipp. The network helps show where Eli Ipp may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli Ipp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1978 | 217 | |
| 2 | 2012 | 165 | |
| 3 | 1977 | 142 | |
| 4 | 2005 | 135 | |
| 5 | 1978 | 131 | |
| 6 | 1996 | 123 | |
| 7 | 2001 | 104 | |
| 8 | 1977 | 97 | |
| 9 | 1977 | 90 | |
| 10 | 2004 | 87 | |
| 11 | 1990 | 84 | |
| 12 | 2013 | 76 | |
| 13 | 1982 | 74 | |
| 14 | 2005 | 67 | |
| 15 | 1980 | 67 | |
| 16 | 1977 | 53 | |
| 17 | 1992 | 52 | |
| 18 | 1993 | 50 | |
| 19 | 2009 | 50 | |
| 20 | Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum components. | 1977 | 48 |
About Eli Ipp
Eli Ipp is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Epidemiology and Ophthalmology, having authored 87 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (29 papers), Diabetes Management and Research (18 papers), Neuroendocrine Tumor Research Advances (14 papers), Retinal Diseases and Treatments (13 papers), Metabolism, Diabetes, and Cancer (11 papers), Retinal Imaging and Analysis (7 papers), Diabetes and associated disorders (7 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (948 citations), Nephrology (272 citations), Endocrine and Autonomic Systems (180 citations), Surgery (1.0k citations) and Cellular and Molecular Neuroscience (461 citations). Eli Ipp has collaborated with scholars based in United States, Taiwan and Switzerland. Frequent co-authors include Roger H. Unger, Richard Dobbs, Hsu-Fang Chou, V. Harris, Lelio Orci, Pauline Genter, Nancy Berman, Wylie Vale, V. Schusdziarra and Akira Arimura. Their work appears in journals such as Diabetes, The Journal of Clinical Endocrinology & Metabolism, Life Sciences, American Journal of Physiology-Endocrinology and Metabolism and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.